
|Videos|June 17, 2016
Fulvestrant Plus Palbociclib in Breast Cancer
Author(s)Joanne Blum, MD, PhD, FACP
Joanne Blum, MD, PhD, FACP, physician, Texas Oncology, discusses the combination of fulvestrant and palbociclib (Ibrance) in patients with breast cancer, as well as the synergy fulvestrant has with other CDK4/6 inhibitors.

















